Volume 8, Number 6:360-440;2018
American Journal of Nuclear Medicine and Molecular Imaging


Chae-Moon Hong, Ho-Sung Ryu, Byeong-Cheol Ahn: Early perfusion and dopamine transporter imaging using 18F-FP-CIT PET/CT in patients with parkinsonism. Am J Nucl Med Mol Imaging 2018;8(6):360-372. (Abstract ajnmmi0087564, Full text, PDF).

Hyung-Jun Im, Meiyappan Solaiyappan, Inki Lee, Tyler Bradshaw, Najat C Daw, Fariba Navid, Barry L Shulkin, Steve Y Cho: Multi-level otsu method to define metabolic tumor volume in positron emission tomography. Am J Nucl Med Mol Imaging 2018;8(6):373-386. (Abstract ajnmmi0087887, Full text, PDF).

Francesco Fiz, Matteo Bauckneht, Arnoldo Piccardo, Cristina Campi, Alberto Nieri, Roberta Piva, Giulia Ferrarazzo, Nathan Artom, Silvia Morbelli, Cecilia Marini, Michele Piana, Marcello Bagnasco, Marco Canepa, Gianmario Sambuceti: Metabolic and densitometric correlation between atherosclerotic plaque and trabecular bone: an 18F-Natrium-Fluoride PET/CT study. Am J Nucl Med Mol Imaging 2018;8(6):387-396. (Abstract ajnmmi0087094, Full text, PDF).

Ewa Pasquereau-Kotula, Benoit Hosten, Fortune Hontonnou, Nicolas Vignal, Florent Antoni, Jean-Luc Poyet, Nathalie Rizzo-Padoin, Laure Sarda-Mantel: Evaluation of planar bioluminescence imaging and microPET/CT for therapy monitoring in a mouse model of pigmented metastatic melanoma. Am J Nucl Med Mol Imaging 2018;8(6):397-406. (Abstract ajnmmi0087675, Full text, PDF).

Raheleh Taghvaei, Mahdi Zirakchian Zadeh, Reza Sirous, Sara Pourhassan Shamchi, William Y Raynor, Siavash Mehdizadeh Seraj, Mateen Moghbel, Shiyu Wang, Thomas J Werner, Hongming Zhuang, Abass Alavi: Pre-treatment partial-volume-corrected TLG is the best predictor of overall survival in patients with relapsing/refractory non-hodgkin lymphoma following radioimmunotherapy. Am J Nucl Med Mol Imaging 2018;8(6):407-414. (Abstract ajnmmi0087865, Full text, PDF).

Ramin Alipour, Steven Smith, Sandeep K Gupta: Utility of metabolic heterogeneity factor in differentiating malignant versus benign parotid uptake on 18F FDG PET-CT. Am J Nucl Med Mol Imaging 2018;8(6):415-420. (Abstract ajnmmi0080551, Full text, PDF).

Suchitra Sundaram, James Driscoll, Mariano Fernandez-Ulloa, Marcos de Lima, Ehsan Malek: FDG PET imaging in multiple myeloma: implications for response assessments in clinical trials. Am J Nucl Med Mol Imaging 2018;8(6):421-427. (Abstract ajnmmi0080652, Full text, PDF).

Ian R Sigal, Ronnie Sebro: Preclinical PET tracers for the evaluation of sarcomas: understanding tumor biology. Am J Nucl Med Mol Imaging 2018;8(6):428-440. (Abstract ajnmmi0088184, Full text, PDF).
AJNMMI Copyright © 2011-present, All rights reserved. Published by e-Century Publishing Corporation, Madison, WI 53711, USA